Precede Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Design Center Pl Ste 19-500, Boston, M...Phone Number
(617) 356-1457Website
precede.bioRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Precede Biosciences
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw. By unlocking genome-wide transcriptional biology through a novel, comprehensive epigenomics approach, the company enables researchers and clinicians to better understand disease biology in real time. By partnering with developers of new medicines and advancing its own diagnostic tests, Precede Bio is working toward a future in which drug development efforts succeed more frequently and patients can receive minimally invasive diagnostics and treatments aligned to the biology of their disease.Explore more
Precede Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precede Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Precede Biosciences is spiking on competitors!
Click to see if Precede Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Precede Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Precede Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Precede Biosciences
Funding: Get notified immidiatlly once Precede Biosciences has new funding data
Check if Precede Biosciences has recently received funding, and reach out quickly before it becomes old news!
Precede Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Precede Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Precede Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Precede Biosciences.
Precede Biosciences financials insights
Gather financial insights about Precede Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series B
$83.5M
Precede Biosciences Tech Stack
A closer look at the technologies used by Precede Biosciences
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Precede Biosciences News & Media
Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026
BOSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Precede Biosciences, a company powering next-generation precision medicine through its comprehensive epigenomic liquid biopsy platform, today announced the launch of Precede Bio Insight™ and the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting, held April 17–22 in San Diego, California.Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics PlatformPrecede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Precede Biosciences Presents New Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in SCLC
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precede Biosciences
Sign Up For FreeTo access detailed company insights
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw. By unlocking genome-wide transcriptional biology through a novel, comprehensive epigenomics approach, the company enables researchers and clinicians to better understand disease biology in real time. By partnering with developers... Read More
